Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis

NCT01807286 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Sponsor requested termination

Conditions

Myeloma

Interventions

DRUG: Pomalidomide
DRUG: Melphalan
DRUG: Dexamethasone
BEHAVIORAL: Questionnaires

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]